19962-04-0

Basic information

• Product Name: 3-AMINOPHENYL N,N-DIMETHYLCARBAMATE, 97
• Synonyms: 3-AMINOPHENYL N,N-DIMETHYLCARBAMATE, 97;3-aminophenyl N,N-dimethylcarbamate;3-Aminophenyl dimethylcarbamate
• CAS NO: 19962-04-0
• Molecular Formula: C₉H₁₂N₂O₂
• Molecular Weight: 180.20378
• Mol File: 19962-04-0.mol

Chemical Properties

• Melting Point: 85℃
• Boiling Point: 313°Cat760mmHg
• Flash Point: 143.1°C
• Appearance: /
• Density: 1.176g/cm³
• Vapor Pressure: 0.000511mmHg at 25°C
• Refractive Index: 1.569
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 3.69±0.10(Predicted)
• CAS DataBase Reference: 3-AMINOPHENYL N,N-DIMETHYLCARBAMATE, 97(CAS DataBase Reference)
• NIST Chemistry Reference: 3-AMINOPHENYL N,N-DIMETHYLCARBAMATE, 97(19962-04-0)
• EPA Substance Registry System: 3-AMINOPHENYL N,N-DIMETHYLCARBAMATE, 97(19962-04-0)

Safety Data

• Safety Statements: S24/25:Avoid contact with skin and eyes.
• Hazardous Substances Data: 19962-04-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
3-AMINOPHENYL N,N-DIMETHYLCARBAMATE, 97 is used as a reagent in organic synthesis for the production of various chemical compounds. Its unique structure allows for a wide range of reactions, making it a valuable component in the synthesis of new molecules.
Used in Pharmaceutical Production:
3-AMINOPHENYL N,N-DIMETHYLCARBAMATE, 97 serves as a precursor in the manufacturing of pharmaceuticals. Its presence in the synthesis process contributes to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Production:
3-AMINOPHENYL N,N-DIMETHYLCARBAMATE, 97 is also utilized as a precursor in the production of agrochemicals, which are essential for enhancing crop protection and improving agricultural yields.
Used in Dye and Pigment Manufacturing:
3-AMINOPHENYL N,N-DIMETHYLCARBAMATE, 97 is used as an intermediate in the manufacturing of dyes and pigments, contributing to the creation of a diverse range of colorants for various industries.
Used in Research and Development:
In the field of research and development, 3-AMINOPHENYL N,N-DIMETHYLCARBAMATE, 97 is employed for the synthesis of new compounds with potential biological activity. Its involvement in innovative chemical processes aids in the discovery of novel substances with beneficial properties.

InChI:InChI=1/C9H12N2O2/c1-11(2)9(12)13-8-5-3-4-7(10)6-8/h3-6H,10H2,1-2H3

Upstream product

• 114-80-7 Neostigmine bromide 
• 74-83-9 methyl bromide 
• 591-27-5 m-Hydroxyaniline 
• 79-44-7 N,N-Dimethylcarbamoyl chloride 
• 554-84-7 meta-nitrophenol 
• 7304-99-6 N,N-dimethyl-carbamic acid 3-nitro-phenyl ester 
• 67-56-1 methanol 
• 1116570-97-8 (S)-3-[2-methyl-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboxamido]phenyl N,N-dimethylcarbamate 
• 7244-70-4 4-nitrophenyl dimethylcarbamate 

Downstream Products

• 1116570-97-8 (S)-3-[2-methyl-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboxamido]phenyl N,N-dimethylcarbamate 
• 1192189-94-8 tert-butyl 4-(tert-butoxycarbonylamino)-4-[3-(N,N-dimethylcarbamoyloxy)phenylcarbamoyl]piperidine-1-carboxylate 
• 1192189-53-9 tert-butyl 4-(benzyloxymethyl)-4-(3-(dimethylcarbamoyloxy)-phenylcarbamoyl)piperidine-1-carboxylate 
• 1192189-83-5 tert-butyl 4-[3-(N,N-dimethylcarbamoyloxy)phenylcarbamoyl]-4-[(1-trityl-1H-imidazol-4-yl)methyl]piperidine-1-carboxylate 
• 1192189-46-0 tert-butyl 4-[3-(N,,N-dimethylcarbamoyloxy)phenylcarbamoyl]-4-methylpiperidine-1-carboxylate 
• 1192189-49-3 tert-butyl 4-benzyl-4-(3-(dimethylcarbamoyloxy)-phenylcarbamoyl)piperidine-1-carboxylate 
• 1192189-57-3 tert-butyl 4-(3-(dimethylcarbamoyloxy)phenylcarbamoyl)-4-(methoxymethyl)piperidine-1-carboxylate 
• 1192189-62-0 tert-butyl 4-[3-(N,N-dimethylcarbamoyloxy)phenylcarbamoyl]-4-(2-methoxyethoxy)piperidine-1-carboxylate 
• 1192189-67-5 tert-butyl 4-[(benzyloxycarbonylamino)methyl]-4-[3-(N,N-dimethylcarbamoyloxy)phenylcarbamoyl]piperidine-1-carboxylate 
• 1192189-77-7 tert-butyl 4-[2-(dimethylamino)ethyl]-4-[3-(N,N-dimethylcarbamoyloxy)phenylcarbamoyl]piperidine-1-carboxylate 
• 1192189-88-0 tert-butyl 4-(benzyloxy)-4-[3-(N,N-dimethylcarbamoyloxy)phenylcarbamoyl]piperidine-1-carboxylate 
• 1309763-45-8 tert-butyl 4-(3-(dimethylcarbamoyloxy)phenylcarbamoyl)-4-(2-methoxyethoxy)piperidine-1-carboxylate 
• 1192189-89-1 3-[4-(benzyloxy)piperidine-4-carboxamido]phenyl N,N-dimethylcarbamate hydrochloride 
• 1192189-85-7 3-[4-benzyloxy-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido]phenyl N,N-dimethylcarbamate 

Relevant articles and documents

HIGHLY CHEMOSELECTIVE REACTIONS IN PRESENCE OF AROMATIC AMINO GROUPS

: The invention discloses a novel process for highly chemoselective reactions of substituted anilines without any detectable reaction at aromatic amino group. The invention also relates to a novel process for preparation of neostigmine methylsulphate via chemoselective reaction of 3-amionphenol and aryl dimethylcarbamates.

Carbazole-rivastigmine diad and pharmaceutical composition and application thereof

The invention provides compounds of the structure as shown in the description or pharmaceutical salt, a pharmaceutical composition and application of the compounds. The compounds relate to a series of carbazole and rivastigmine diads. The carbazole and ri

Discovery and development of LX7101, a dual LIM-kinase and ROCK inhibitor for the treatment of glaucoma

The structure of LX7101, a dual LIM-kinase and ROCK inhibitor for the treatment of ocular hypertension and associated glaucoma, is disclosed. Previously reported LIM kinase inhibitors suffered from poor aqueous stability due to solvolysis of the central urea. Replacement of the urea with a hindered amide resulted in aqueous stable compounds, and addition of solubilizing groups resulted in a set of compounds with good properties for topical dosing in the eye and good efficacy in a mouse model of ocular hypertension. LX7101 was selected as a clinical candidate from this group based on superior efficacy in lowering intraocular pressure and a good safety profile. LX7101 completed IND enabling studies and was tested in a Phase 1 clinical trial in glaucoma patients, where it showed efficacy in lowering intraocular pressure. (Figure Presented).

An efficient method for the protection of aromatic amines with benzostabase and its utility in anionic aromatic transformations

Herein we describe an efficient and generally applicable method of protecting a diverse series of aromatic amines with the 'benzostabase' group. We also demonstrate its efficient use in aromatic anionic chemistry including its utility in the anionic ortho

Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma

The discovery of a pyrrolopyrimidine class of LIM-kinase 2 (LIMK2) inhibitors is reported. These LIMK2 inhibitors show good potency in enzymatic and cellular assays and good selectivity against ROCK. After topical dosing to the eye in a steroid induced mouse model of ocular hypertension, the compounds reduce intraocular pressure to baseline levels. The compounds also increase outflow facility in a pig eye perfusion assay. These results suggest LIMK2 may be an effective target for treating ocular hypertension and associated glaucoma.

KINASE INHIBITORS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE

Inhibitors of LIM kinase 2 are disclosed, along with pharmaceutical compositions comprising them and methods of their use